Physician profile
Eric J Eichhorn
NPI 1972595510
$14,047.37
in general payments reported to CMS, 2019-2025
52 companies · $3,128 in 2025
The $3,128 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,120 · 2020: $569 · 2021: $1,660 · 2022: $2,082 · 2023: $2,110 · 2024: $2,377 · 2025: $3,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,573 · Education: $42.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,572.52 |
| Education | $42.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $1,561.50 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Amgen INC. | $1,046.57 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $1,006.78 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $905.39 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Novartis Pharmaceuticals Corporation | $824.06 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $663.89 | 2019-2025 | Lifevest |
| Heartflow, INC. | $642.13 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $634.31 | 2019-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $614.43 | 2019-2025 | |
| Abiomed | $551.78 | 2023-2025 | Impella |
| Amarin Pharma, INC. | $505.83 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $495.46 | 2019-2023 | |
| Inspire Medical Systems, INC. | $392.81 | 2023-2025 | Inspire |
| Kestra Medical Technology Services, INC. | $318.75 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $314.47 | 2019-2025 | Wainua, Farxiga, Andexxa |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $291.36 | 2021-2025 | Inspiris Resilia Aortic Valve |
| Alnylam Pharmaceuticals INC. | $284.37 | 2019-2025 | Onpattro, Amvuttra |
| Janssen Pharmaceuticals, INC | $279.41 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $206.16 | 2019-2021 | |
| Boston Scientific Corporation | $201.66 | 2019-2025 | Farapulse |
| Abbott Laboratories | $194.39 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx, Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.79 | 2022-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $187.11 | 2022-2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $162.34 | 2021-2023 | Arcalyst |
| Medtronic, INC. | $159.47 | 2021-2025 | Symplicity G3 |
| Novo Nordisk INC | $149.36 | 2021-2025 | Ozempic, Rybelsus |
| Bridgebio Pharma, INC. | $145.60 | 2025 | Attruby |
| Medtronic Vascular, INC. | $145.36 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $135.63 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $96.89 | 2022-2024 | Nexletol |
| Philips North America LLC | $81.15 | 2020-2025 | Extended Holter, (Ck7) Extended Holter |
| Vital Connect, INC | $63.27 | 2023-2025 | Vitalpatch Rtm |
| Lexicon Pharmaceuticals, INC. | $47.59 | 2023-2024 | Inpefa |
| Irhythm Technologies, INC. | $46.74 | 2019-2022 | |
| Bardy Diagnostics, INC. | $46.00 | 2019 | |
| Cardiovascular Systems INC. | $45.92 | 2019 | |
| Recor Medical INC | $45.17 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Regeneron Healthcare Solutions, INC. | $43.93 | 2019 | |
| Itamar Medical INC | $33.87 | 2021 | |
| Gilead Sciences, INC. | $33.67 | 2019 | |
| Shockwave Medical, INC | $29.65 | 2025 | |
| Bard Peripheral Vascular, INC. | $28.19 | 2021 | |
| Sensible Medical Innovations INC | $27.65 | 2025 | Reds System |
| Baxter Healthcare | $26.86 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Daiichi Sankyo INC. | $26.19 | 2024 | Injectafer |
| Acist Medical Systems, INC. | $22.34 | 2020 | |
| Avinger INC. | $21.77 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.71 | 2020 | |
| Lundbeck LLC | $15.25 | 2020 | |
| Chiesi USA, INC. | $13.84 | 2019 | |
| Tactile Systems Technology INC | $12.78 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $8.77 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Eichhorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.